[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100605859":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":37,"locations":45,"responsibleParty":64,"collaborators":26,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":26,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":75,"enrollmentInfo":76,"targetDuration":26,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":87,"overallStatus":102,"whyStopped":26,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":112},{"fullName":5,"class":6},"Wolfson Medical Center","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Video","EXPERIMENTAL","Participants in this group will view a short (up to 5 minutes) informative video. The video explains the rationale, procedure, and safety of LMWH to reduce anxiety and increase patient understanding prior to the first injection.",[13],"Behavioral: Informative Video on LMWH",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group","ACTIVE_COMPARATOR","Participants in this group will receive only a verbal explanation regarding postpartum LMWH (Clexane) administration, without any additional video intervention. This represents the current standard of care",[19],"Behavioral: Standard Verbal Explanation",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"BEHAVIORAL","Informative Video on LMWH","A short (up to 5 minutes) informative video presented to postpartum women prior to their first LMWH (Clexane) injection. The video explains the rationale, process, and safety of LMWH use for thrombopr",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Standard Verbal Explanation","Participants receive the routine verbal explanation regarding postpartum LMWH (Clexane) administration, covering its purpose and method of injection",[15],[32,35],{"name":33,"affiliation":5,"role":34},"Matan Friedman, MD","PRINCIPAL_INVESTIGATOR",{"name":36,"affiliation":5,"role":34},"Amihai Rottenstreich, MD",[38,42],{"name":33,"role":39,"phone":40,"phoneExt":26,"email":41},"CONTACT","+972 54-421-0360","matan.friedman@gmail.com",{"name":36,"role":39,"phone":43,"phoneExt":26,"email":44},"+972 50-688-4171","amichaimd@gmail.com",[46],{"facility":5,"status":26,"city":47,"state":26,"zip":26,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Holon","Israel","IL",{"type":51,"coordinates":52},"Point",[53,54],34.77918,32.01034,{"lat":54,"lon":53},[57,58,62,63],{"name":33,"role":39,"phone":40,"phoneExt":26,"email":41},{"name":59,"role":39,"phone":60,"phoneExt":26,"email":61},"Hagit Eisenberg, MD","+972523397843","hagiteisen@yahoo.com",{"name":33,"role":34,"phone":26,"phoneExt":26,"email":26},{"name":36,"role":34,"phone":26,"phoneExt":26,"email":26},{"type":65,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100605859","informative-video-before-lmwh-postpartum---randomized-controlled-trial-100605859",false,"NCT07168005","Informative Video Before LMWH Postpartum - Randomized Controlled Trial","Does an Informative Video Reduce Anxiety and Pain Before LMWH Treatment Postpartum? - A Randomized Controlled Trial","Inclusion Criteria:\n\nWomen 18-45 years, postpartum, indicated for LMWH, Hebrew-literate, gave consent\n\nExclusion Criteria:\n\nUse of LMWH pre-delivery, IUFD, pregnancy termination, language\u002Fcognitive barrier","FEMALE","18 Years","45 Years",{"count":77,"type":78},160,"ESTIMATED","INTERVENTIONAL",[81],"NA","This single-center randomized controlled trial evaluates whether a short informative video can reduce anxiety and pain before the first postpartum administration of low molecular weight heparin (LMWH, Clexane). Eligible women will be randomized to receive either standard explanation alone or standard explanation plus a short educational video. The primary outcome is anxiety level assessed via the State-Trait Anxiety Inventory (STAI). Secondary outcomes include pain, satisfaction, and treatment adherence.",[84,85,86],"Venous Thromboembolism (VTE)","Postpartum Care","Anxiety",[88,89,90,91,92,93,86,94,95,96,97,98,85,99,100,101],"Postpartum","Venous Thromboembolism","VTE","LMWH","Low Molecular Weight Heparin","Clexane","Pain","Patient Education","Informative Video","State-Trait Anxiety Inventory","STAI","Women's Health","Obstetrics","Adherence","NOT_YET_RECRUITING","2025-09-03",{"date":105,"type":106},"2025-09-11","ACTUAL",{"date":108,"type":78},"2025-10-15",{"date":110,"type":78},"2027-10-15",{"name":5,"class":6},1]